Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Clinical Lymphoma, Myeloma & Leukemia|September 6, 2018
Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia RelapseKiyomi Mashima, Iekuni Oh, Takashi Ikeda, et al.
Acta Histochemica Et Cytochemica|July 7, 2020
Differential Localization and Invasion of Tumor Cells in Mouse Models of Human and Murine LeukemiasKiyomi Mashima, Morio Azuma, Ken Fujiwara, et al.
International Journal of Hematology|March 20, 2021
Risk factors for high-dose methotrexate-induced nephrotoxicityShinichiro Kawaguchi, Shin-Ichiro Fujiwara, Rui Murahashi, et al.
Transplantation|August 29, 2019
Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD ModelsYasufumi Kawasaki, Kazuya Sato, Hirofumi Nakano, et al.
Cancer Genetics|January 10, 2018
A leukemic double-hit follicular lymphoma associated with a complex variant translocation, t(8;14;18)(q24;q32;q21), involving BCL2, MYC, and IGHDaisuke Minakata, Kazuya Sato, Takashi Ikeda, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2019
Salvage Chemotherapy Followed by Autologous Stem-Cell Transplantation Using Targeted Busulfan for Refractory Diffuse Large B-Cell Lymphoma With Dialysis-Dependent End-Stage Renal DiseaseKaoru Morita, Masahiro Ashizawa, Yumiko Toda, et al.
International Journal of Hematology|November 16, 2019
The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatinKento Umino, Kaoru Hatano, Shin-Ichi Ochi, et al.
Annals of Hematology|November 9, 2020
Clinical association between thyroid disease and immune thrombocytopeniaShoko Ito, Shin-Ichiro Fujiwara, Rui Murahashi, et al.
Annals of Hematology|June 24, 2020
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myelomaTakashi Nagayama, Masahiro Ashizawa, Takashi Ikeda, et al.
Annals of Hematology|June 27, 2019
Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapyKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pageof 7